Lipocine Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2011
Revenue	-2.85	0.5	16.14	0	0.16	Upgrade
Revenue Growth (YoY)	-	-96.90%	-	-	-61.45%	Upgrade
Gross Profit	-2.85	0.5	16.14	0	0.16	Upgrade
Selling, General & Admin	4.9	4.06	5.33	8.25	5.6	Upgrade
Research & Development	10.18	8.56	7.67	9.75	7.47	Upgrade
Operating Expenses	15.08	12.62	13	18	13.07	Upgrade
Operating Income	-17.93	-12.12	3.15	-18	-12.9	Upgrade
Interest Expense / Income	0	0.03	0.2	0.39	0.77	Upgrade
Other Expense / Income	-1.58	-1.39	3.58	2.58	-0.66	Upgrade
Pretax Income	-16.35	-10.76	-0.63	-20.96	-13.01	Upgrade
Income Tax	0	0	0	0	0	Upgrade
Net Income	-16.35	-10.76	-0.63	-20.96	-13.01	Upgrade
Preferred Dividends	0	0	0	0	0	Upgrade
Net Income Common	-16.35	-10.76	-0.63	-20.96	-13.01	Upgrade
Shares Outstanding (Basic)	5	5	5	3	2	Upgrade
Shares Outstanding (Diluted)	5	5	5	3	2	Upgrade
Shares Change	0.26%	1.98%	57.35%	115.16%	21.22%	Upgrade
EPS (Basic)	-3.10	-2.06	-0.17	-6.46	-8.50	Upgrade
EPS (Diluted)	-3.14	-2.15	-0.17	-6.46	-8.50	Upgrade
Free Cash Flow	-11.88	-12.1	-4.42	-15.3	-11.67	Upgrade
Free Cash Flow Per Share	-2.25	-2.31	-0.86	-4.67	-7.66	Upgrade
Gross Margin	-	100.00%	100.00%	-	100.00%	Upgrade
Operating Margin	-	-2423.88%	19.49%	-	-7818.83%	Upgrade
Profit Margin	-	-2151.73%	-3.93%	-	-7883.72%	Upgrade
Free Cash Flow Margin	-	-2420.53%	-27.38%	-	-7070.86%	Upgrade
EBITDA	-16.32	-10.72	-0.43	-20.57	-12.22	Upgrade
EBITDA Margin	-	-2144.28%	-2.67%	-	-7409.51%	Upgrade
Depreciation & Amortization	0.03	0.01	0	0	0.02	Upgrade
EBIT	-16.35	-10.73	-0.43	-20.58	-12.24	Upgrade
EBIT Margin	-	-2146.17%	-2.67%	-	-7418.87%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).